Physical Activity and Cancer: How Staying Active Helps Fight Cancer Progression and Mortality in South Africa

Original Article: https://bjsm.bmj.com/content/early/2025/01/02/bjsports-2024-108813.info

Why Physical Activity Matters for Cancer

Cancer is a major cause of death worldwide, with around 10 million deaths annually. About 30–40% of cancers can be prevented by addressing lifestyle factors like smoking, poor diet, obesity, and … [Read More]

Radon Exposure and Gestational Diabetes Risk: What We Know

Original Article: https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2828917?

Introduction: Understanding the Issue

Gestational diabetes mellitus (GDM) is a condition where an individual has diabetes during pregnancy, affecting about 10% of pregnancies in the U.S. yearly. As well as being associated with adverse outcomes for the … [Read More]

Screening and Telephone-Based Intervention for Unhealthy Alcohol Use in Texas Clinics

Original Article: https://link.springer.com/article/10.1007/s11606-024-09240-5

Addressing Unhealthy Alcohol Use

Unhealthy alcohol use, such as binge drinking or alcohol use disorder (AUD), increases the risk of health problems like liver disease, heart disease, and cancer. Despite recommendations for routine screening and treatment, only … [Read More]

A New Hope for Stronger Bones in Older Women with Diabetes  

Original Article: https://academic.oup.com/jcem/advance-article-abstract/doi/10.1210/clinem/dgae700/7815469?redirectedFrom=fulltext&login=false

How Pyridoxamine May Protect Bone Health

In a study of older postmenopausal women with type 2 diabetes (T2D), researchers explored pyridoxamine, a vitamin B6 metabolite, as a potential treatment for improving bone health. Pyridoxamine targets advanced glycation … [Read More]

Decline in Bariatric Surgery as GLP-1 Medications Rise  

Original Article: https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2825349

GLP-1 Medications Gaining Popularity

New medications called Glucagon Like Peptide-1 Receptor Agonists (known as GLP-1 RAs such as Semaglutide and Liraglutide), have grown increasingly popular for people with type 2 diabetes and/or obesity. These medications are used … [Read More]

Gaps in Obesity Care: A Call for Better Education

Original Article: https://www.medscape.com/viewarticle/knowledge-gaps-about-obesity-medicine-seen-primary-care-2024a1000k9c

Limited Knowledge Among Providers

A study at a Boston safety-net hospital revealed significant knowledge gaps in obesity care among primary care providers. Out of 96 surveyed, many lacked confidence in prescribing anti-obesity medications (AOMs), especially non-GLP-1 options. … [Read More]